Insulin secretion induced by glucose and by stimulation of β2-adrenoceptors in the rat. Different sensitivity to somatostatin
- 1 August 1981
- journal article
- research article
- Published by Wiley in Acta Physiologica Scandinavica
- Vol. 112 (4), 421-426
- https://doi.org/10.1111/j.1748-1716.1981.tb06839.x
Abstract
The effects of somatostatin on insulin secretion stimulated by glucose or by the selective .beta.2-adrenoceptor agonist terbutaline were studied in vivo in the anesthetized rat. Infusion of low doses of glucose (5 mg/min) or terbutaline (2 .mu.g/min) caused slight stimulation of insulin secretion; infusion of higher doses of glucose (12.5 mg/min) or terbutaline (200 .mu.g/min) yielded higher rates of insulin release. In both instances plasma insulin concentrations were of comparable magnitudes immediately prior to somatostatin infusion. Somatostatin (0.1 .mu.g/min) inhibited the insulin response to glucose and terbutaline, both at the low and high secretory rates. The inhibitory effect of somatostatin was much more pronounced on insulin release during glucose infusion than during infusion of terbutaline. At the high rate of insulin secretion somatostatin depressed plasma insulin by 46% during glucose and by 22% during terbutaline infusion. The results at the low rate of insulin secretion were 66 and 48%, respectively. Both at high and low secretory rates somatostatin depressed plasma insulin levels more potently during glucose infusion than during terbutaline infusion (P < 0.001 and P < 0.05, respectively). The plasma insulin levels during inhibition by somatostatin following terbutaline stimulation stabilized after .apprx. 10 min of somatostatin infusion; following glucose stimulation the insulin levels continued to decline. Evidently, somatostatin inhibits insulin secretion via mechanisms that are more closely related to the insulin secretory pathway induced by glucose than to that induced by .beta.-adrenoceptor agonists.Keywords
This publication has 20 references indexed in Scilit:
- Certain pharmacological characteristics of the release of pancreatic glucagon in response to stimulation of the splanchnic nerves.The Journal of Physiology, 1978
- Enzymatic microdetermination of glycogenAnalytical Biochemistry, 1978
- Interrelationship of Calcium and Somatostatin in the Secretion of Insulin and GlucagonPublished by Springer Nature ,1977
- STUDIES ON THE MECHANISM OF SOMATOSTATIN ACTION ON INSULIN RELEASE IN MANActa Endocrinologica, 1976
- Somatostatin Inhibition of Insulin and Glucagon Secretion in Rat Islet Culture: Reversal by Ionophore A231871Endocrinology, 1976
- Inhibition by somatostatin of glucose induced 3′: 5′-monophosphate (Cyclic AMP) accumulation and insulin release in isolated pancreatic islets of the ratFEBS Letters, 1975
- Inhibition by Somatostatin of Glucagon and Insulin Release from the Perfused Rat Pancreas in Response to Arginine, Isoproterenol and Theophylline: Evidence for a Preferential Effect on Glucagon SecretionEndocrinology, 1975
- Reversal of somatostatin inhibition of insulin secretion by calciumBiochemical and Biophysical Research Communications, 1974
- The Stimulus-Secretion Coupling of Glucose-Induced Insulin Release. VII. A PROPOSED SITE OF ACTION FOR ADENOSINE-3′,5′-CYCLIC MONOPHOSPHATEJCI Insight, 1972
- Two new groups of selective stimulants of adrenergicβ-receptorsCellular and Molecular Life Sciences, 1969